Navigating science communication from early-stage to IPO

What does it take to scale biotech communications from a small startup to a successful IPO? In this episode, I sit down with Ariel Kramer, Founder of Klover Communications and former Chief Communications Officer at BICO, to break it all down. Ariel shares what she learned while helping BICO grow from just a few employees to a publicly traded company—covering the biggest communication challenges, PR mistakes to avoid, and why storytelling is key in biotech marketing. We also dive into what it means to become a trusted industry resource, the differences between in-house and agency life, and how to build a career in life sciences communication.

In this episode, you'll learn:
00:00 Introduction
01:24 The communication challenges of a bioprinting startup
04:42 How an IPO impacts communication
07:38 Creating an educational hub in biotech
12:51 The danger of false promises in science communication
15:43 Navigating the data drought in life sciences
19:56 Misconceptions about PR in scientific startups
22:49 Understanding the realities of PR guarantees
28:17 Building a career in science communication
31:58 Comparing in-house and agency communication roles
35:02 Resources for aspiring science communicators

Companies mentioned:

• BICO
• Every Cure

References:

• Article from STAT on AI biotech companies
• Ticket to Biotech

To connect with Ariel:

• LinkedIn
• Klover Communications

To connect with Joachim Eeckhout, host of the podcast:

• LinkedIn
• Contact form

>>> Subscribe to The Science Marketer newsletter <<<